Sumpatan, Evelyn D.

HRN: 08-18-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2023
CEFTRIAXONE 1G (VIAL)
12/10/2023
12/17/2023
IV
2g
Q24
Cap Mr
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  PneumoniaProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: